Israel Englander’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.19M Buy
+125,000
New +$5.04M ﹤0.01% 2968
2024
Q2
Sell
-20,300
Closed -$593K 6349
2024
Q1
$593K Buy
+20,300
New +$615K ﹤0.01% 4701
2018
Q4
Sell
-30,900
Closed -$2.22M 4061
2018
Q3
$2.22M Buy
+30,900
New +$1.95M ﹤0.01% 2374

Other funds holding OMCL

Israel Englander's OMCL Position: Q2 2026 in Review

Israel Englander reduced its Omnicell (OMCL) stake by 24% in Q2 2026, selling an estimated $22.3M and leaving 1,734,375 shares worth $72M. The position accounts for 0.03% of the portfolio, ranked #684.

Israel Englander first reported a position in OMCL in Q2 2013 and has held it in 37 quarters since. The position peaked at $79M in Q4 2025. 304 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • Israel Englander held 1,734,375 shares of Omnicell worth $72M as of Q2 2026.
  • Israel Englander sold 554,195 Omnicell shares in Q2 2026, an estimated $22.3M.
  • Omnicell made up 0.03% of Israel Englander's portfolio in Q2 2026, its #684 holding.
  • Israel Englander first reported a position in Omnicell in Q2 2013 and has held it in 37 quarters since.
  • Israel Englander's Omnicell position peaked at $79M in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.